期刊文献+

Irritable bowel syndrome and organic diseases: A comparative analysis of esophageal motility 被引量:1

Irritable bowel syndrome and organic diseases: A comparative analysis of esophageal motility
下载PDF
导出
摘要 AIM:To assess the esophageal motility in patients with irritable bowel syndrome(IBS)and to compare those with patients with autoimmune disorders.METHODS:15 patients with IBS,22 with systemic lupus erythematosus(SLE)and 19 with systemic sclerosis(SSc)were prospectively selected from a total of 115patients at a single university centre and esophageal motility was analysed using standard manometry(Mui Scientific PIP-4-8SS).All patients underwent esophagogastro-duodenoscopy before entering the study so that only patients with normal endoscopic findings were included in the current study.All patients underwent a complete physical,blood biochemistry and urinary examination.The grade of dysphagia was determined for each patient in accordance to the intensity and frequency of the presented esophageal symptoms.Furthermore,disease activity scores(SLEDAI and modified Rodnan score)were obtained for patients with autoimmune diseases.Outcome parameter:A correlation coefficient was calculated between amplitudes,velocity and duration of the peristaltic waves throughout esophagus and patients’dysphagia for all three groups.RESULTS:There was no statistical difference in the standard blood biochemistry and urinary analysis in all three groups.Patients with IBS showed similar pathologic dysphagia scores compared to patients with SLE and SSc.The mean value of dysphagia score was in IBS group 7.3,in SLE group 6.73 and in SSc group7.56 with a P-value>0.05.However,the manometric patterns were different.IBS patients showed during esophageal manometry peristaltic amplitudes at the proximal part of esophagus greater than 60 mmHg in46%of the patients,which was significant higher in comparison to the SLE(11.8%)and SSc-Group(0%,P=0.003).Furthermore,IBS patients showed lower mean resting pressure of the distal esophagus sphincter(Lower esophageal sphincter,22 mmHg)when compared with SLE(28 mmHg,P=0.037)and SSc(26 mmHg,P=0.052).23.5%of patients with SLE showed amplitudes greater as 160 mmHg in the distal esophagus(IBS and SSc:0%)whereas 29.4%amplitudes greater as 100 mmHg in the middle one(IBS:16.7%,SSc:5.9%respectively,P=0.006).Patients with SSc demonstrated,as expected,in almost half of the cases reduced peristalsis or even aperistalsis in the lower two thirds of the esophagus.SSc patients demonstrated a negative correlation coefficient between dysphagia score,amplitude and velocity of peristaltic activity at middle and lower esophagus[r=-0.6,P<CONCLUSION:IBS patients have comparable dysphagia-scores as patients with autoimmune disorders.The different manometric patterns might allow differentiating esophageal symptoms based on IBS from other organic diseases. AIM: To assess the esophageal motility in patients with irritable bowel syndrome (IBS) and to compare those with patients with autoimmune disorders. METHODS: 15 patients with IBS, 22 with systemic lupus erythematosus (SLE) and 19 with systemic sclerosis (SSc) were prospectively selected from a total of 115 patients at a single university centre and esophageal motility was analysed using standard manometry (Mui Scientific PIP-4-8SS). All patients underwent esophago-gastro-duodenoscopy before entering the study so that only patients with normal endoscopic findings were included in the current study. All patients underwent a complete physical, blood biochemistry and urinary examination. The grade of dysphagia was determined for each patient in accordance to the intensity and frequency of the presented esophageal symptoms. Furthermore, disease activity scores (SLEDAI and modified Rodnan score) were obtained for patients with autoimmune diseases. Outcome parameter: A correlation coefficient was calculated between amplitudes, velocity and duration of the peristaltic waves throughout esophagus and patients’ dysphagia for all three groups. RESULTS: There was no statistical difference in the standard blood biochemistry and urinary analysis in all three groups. Patients with IBS showed similar pathologic dysphagia scores compared to patients with SLE and SSc. The mean value of dysphagia score was in IBS group 7.3, in SLE group 6.73 and in SSc group 7.56 with a P-value > 0.05. However, the manometric patterns were different. IBS patients showed during esophageal manometry peristaltic amplitudes at the proximal part of esophagus greater than 60 mmHg in 46% of the patients, which was significant higher in comparison to the SLE (11.8%) and SSc-Group (0%, P = 0.003). Furthermore, IBS patients showed lower mean resting pressure of the distal esophagus sphincter (Lower esophageal sphincter, 22 mmHg) when compared with SLE (28 mmHg, P = 0.037) and SSc (26 mmHg, P = 0.052). 23.5% of patients with SLE showed amplitudes greater as 160 mmHg in the distal esophagus (IBS and SSc: 0%) whereas 29.4% amplitudes greater as 100 mmHg in the middle one (IBS: 16.7%, SSc: 5.9% respectively, P = 0.006). Patients with SSc demonstrated, as expected, in almost half of the cases reduced peristalsis or even aperistalsis in the lower two thirds of the esophagus. SSc patients demonstrated a negative correlation coefficient between dysphagia score, amplitude and velocity of peristaltic activity at middle and lower esophagus [r = -0.6, P < 0.05]. CONCLUSION: IBS patients have comparable dysphagia-scores as patients with autoimmune disorders. The different manometric patterns might allow differentiating esophageal symptoms based on IBS from other organic diseases.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第38期6408-6415,共8页 世界胃肠病学杂志(英文版)
关键词 IRRITABLE bowel syndrome SYSTEMIC lupus ERYTHEMATOSUS SYSTEMIC SCLEROSIS Esophageal MANOMETRY DYSPHAGIA Irritable bowel syndrome Systemic lupus erythematosus Systemic sclerosis Esophageal manometry Dysphagia
  • 相关文献

参考文献44

  • 1Pejman Katiraei,Gilberto Bultron.Need for a comprehensive medical approach to the neuroimmuno-gastroenterology of irritable bowel syndrome[J].World Journal of Gastroenterology,2011,17(23):2791-2800. 被引量:14
  • 2QiQi Zhou,Buyi Zhang,G. Nicholas Verne.Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome[J]. Pain . 2009 (1)
  • 3Ante Bili?,Dragan Jur?i?,Dragan Schwarz,Nikolina Mari?,Aleksandar V?ev,Marinko Maru?i?,Maru?ka Gabri?,Ljubica ?poljari?.Impaired Esophageal Function in Patients with Irritable Bowel Syndrome[J]. Collegium Antropologicum . 2008 (3)
  • 4Patrick P.J. van der Veek,Yanda R. van Rood,Ad A.M. Masclee.Symptom Severity but Not Psychopathology Predicts Visceral Hypersensitivity in Irritable Bowel Syndrome[J]. Clinical Gastroenterology and Hepatology . 2008 (3)
  • 5Mohammad Hassan Emami,Mostafa Raisi,Jaleh Amini,Hamed Daghaghzadeh.Achalasia and thyroid disease[J].World Journal of Gastroenterology,2007,13(4):594-599. 被引量:5
  • 6Ellen C. Ebert.Esophageal Disease in Scleroderma[J]. Journal of Clinical Gastroenterology . 2006 (9)
  • 7Philip Hilgard,Alisan Kahraman,Nils Lehmann,Cornelia Seltmann,Susanne Beckebaum,R Stefan Ross,Hideo A Baba,Massimo Malago,Christoph E Broelsch,Guido Gerken.Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation:Effects on virus replication and recurrent hepatitis[J].World Journal of Gastroenterology,2006,12(5):697-702. 被引量:235
  • 8Maureen D Mayes.Scleroderma epidemiology[J]. Rheumatic Disease Clinics of North America . 2003 (2)
  • 9A. P. S.Hungin,P. J.Whorwell,J.Tack,F.Mearin.The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects[J]. Alimentary Pharmacology & Therapeutics . 2003 (5)
  • 10Lars Agréus,Kurt Sv?rdsudd,Olof Nyrén,G?sta Tibblin.Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time[J]. Gastroenterology . 1995 (3)

二级参考文献81

  • 1Ashkan Farhadi,Jeremy Z Fields,Ali Keshavarzian.Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots:Stress,intestinal hyperpermeability and inflammation[J].World Journal of Gastroenterology,2007,13(22):3027-3030. 被引量:15
  • 2[1]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52.
  • 3[2]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
  • 4[3]Curry MP.Hepatitis B and hepatitis C viruses in liver transplantation.Transplantation 2004; 78:955-963
  • 5[4]Vargas HE,Laskus T,Radkowski M,Wilkinson J,Balan V,Douglas DD,Harrison ME,Mulligan DC,Olden K,Adair D,Rakela J.Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.Liver Transpl 2002; 8:1014-1019
  • 6[5]Yan FM,Chen AS,Hao F,Zhao XP,Gu CH,Zhao LB,Yang DL,Hao LJ.Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.World J Gastroenterol 2000; 6:805-811
  • 7[6]Lamelin JP,Zoulim F,Trepo C.Lymphotropism of hepatitis B and C viruses:an update and a newcomer.Int J Clin Lab Res 1995; 25:1-6
  • 8[7]Gruener NH,Jung MC,Schirren CA.Recurrent hepatitis C virus infection after liver transplantation:natural course,therapeutic approach and possible mechanisms of viral control.J Antimicrob Chemother 2004; 54:17-20
  • 9[8]Porter SB,Reddy KR.Factors that influence the severity of recurrent hepatitis C virus following liver transplantation.Clin Liver Dis 2003; 7:603-614
  • 10[9]Prieto M,Berenguer M,Rayon JM,Cordoba J,Arguello L,Carrasco D,Garcia-Herola A,Olaso V,De Juan M,Gobernado M,Mir J,Berenguer J.High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation:relationship with rejection episodes.Hepatology 1999; 29:250-256

共引文献251

同被引文献12

引证文献1

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部